A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody
暂无分享,去创建一个
W. Fiers | B. Schepens | X. Saelens | Judith Verhelst | E. Job | K. Roose | M. Schotsaert | S. De Baets | A. Smet | Silvie Van den Hoecke | Bert Schepens
[1] X. Saelens,et al. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing , 2015, BMC Genomics.
[2] R. Fouchier,et al. Role of receptor binding specificity in influenza A virus transmission and pathogenesis , 2014, The EMBO journal.
[3] Hari Shroff,et al. Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm , 2014, PLoS pathogens.
[4] William H. Thiel,et al. Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells. , 2013, Virology.
[5] D. Poole,et al. Highly Sensitive Real-Time In Vivo Imaging of an Influenza Reporter Virus Reveals Dynamics of Replication and Spread , 2013, Journal of Virology.
[6] F. Alt,et al. Antigen-specific B cell receptor sensitizes B cells to infection by influenza virus , 2013, Nature.
[7] Jonathan J Deeks,et al. Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.
[8] Weixu Meng,et al. Visualizing influenza virus infection in living mice , 2013, Nature Communications.
[9] K. Subbarao,et al. Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets. , 2013, Virology.
[10] Frederick Klauschen,et al. A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection , 2013, Cell.
[11] N. Heaton,et al. In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies , 2013, Journal of Virology.
[12] Tsunglin Liu,et al. Effects of GC Bias in Next-Generation-Sequencing Data on De Novo Genome Assembly , 2013, PloS one.
[13] Yoshihiro Kawaoka,et al. Receptor binding by a ferret-transmissible H5 avian influenza virus , 2013, Nature.
[14] P. Kellam,et al. Viral population analysis and minority-variant detection using short read next-generation sequencing , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.
[15] D. Pérez,et al. Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines , 2013, Journal of Virology.
[16] Marie R. Griffin,et al. The Burden of Influenza in Young Children, 2004–2009 , 2013, Pediatrics.
[17] R. Langlois,et al. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. , 2013, Cell reports.
[18] W. Fiers,et al. Recombinant Influenza Virus Carrying the Respiratory Syncytial Virus (RSV) F85-93 CTL Epitope Reduces RSV Replication in Mice , 2013, Journal of Virology.
[19] S. Sealfon,et al. Mouse Dendritic Cell (DC) Influenza Virus Infectivity Is Much Lower than That for Human DCs and Is Hemagglutinin Subtype Dependent , 2012, Journal of Virology.
[20] P. Reading,et al. The fate of influenza A virus after infection of human macrophages and dendritic cells. , 2012, The Journal of general virology.
[21] W. Fiers,et al. Natural and long-lasting cellular immune responses against influenza in the M2e-immune host , 2012, Mucosal Immunology.
[22] N. Jojic,et al. HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection , 2012, Proceedings of the National Academy of Sciences.
[23] Paul Kellam,et al. IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.
[24] E. Vermeire,et al. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. , 2011, Vaccine.
[25] H. Park,et al. High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice , 2011, PloS one.
[26] Min-Chul Kim,et al. Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity , 2011, PloS one.
[27] W. Fiers,et al. Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection , 2011, The Journal of Immunology.
[28] T. Muster,et al. Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency , 2010, Journal of Virology.
[29] Andrew C. Adey,et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition , 2010, Genome Biology.
[30] Weiqi Pan,et al. Generation of Replication-Competent Recombinant Influenza A Viruses Carrying a Reporter Gene Harbored in the Neuraminidase Segment , 2010, Journal of Virology.
[31] H. Yen,et al. Host response to influenza virus: protection versus immunopathology. , 2010, Current opinion in immunology.
[32] Bali Pulendran,et al. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus , 2010, Proceedings of the National Academy of Sciences.
[33] Scott N. Mueller,et al. Immunization with Live Attenuated Influenza Viruses That Express Altered NS1 Proteins Results in Potent and Protective Memory CD8+ T-Cell Responses , 2009, Journal of Virology.
[34] S. Inoue,et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. , 2009, Cell host & microbe.
[35] H. Klenk,et al. Influenza receptors, polymerase and host range. , 2009, Revue scientifique et technique.
[36] B. G. Hale,et al. The multifunctional NS1 protein of influenza A viruses. , 2008, The Journal of general virology.
[37] A. Tomoiu,et al. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. , 2008, Annual review of microbiology.
[38] Taeg S. Kim,et al. Differential Response of Respiratory Dendritic Cell Subsets to Influenza Virus Infection , 2008, Journal of Virology.
[39] A. Osterhaus,et al. Predominant Infection of CD150+ Lymphocytes and Dendritic Cells during Measles Virus Infection of Macaques , 2007, PLoS pathogens.
[40] S. Brody,et al. Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells , 2006, Journal of Virology.
[41] H. Katinger,et al. Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment , 2005, Journal of Virology.
[42] Hideo Goto,et al. Importance of both the Coding and the Segment-Specific Noncoding Regions of the Influenza A Virus NS Segment for Its Efficient Incorporation into Virions , 2005, Journal of Virology.
[43] H. Katinger,et al. Rescue of influenza virus expressing GFP from the NS1 reading frame. , 2004, Virology.
[44] H. Klenk,et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. L. Collins,et al. Virus Replication in Engineered Human Cells That Do Not Respond to Interferons , 2003, Journal of Virology.
[46] Robert H. Silverman,et al. Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains , 2002, Journal of Virology.
[47] R. Webster,et al. Eight-plasmid system for rapid generation of influenza virus vaccines. , 2002, Vaccine.
[48] K. Hashimoto,et al. SLAM (CD150)-Independent Measles Virus Entry as Revealed by Recombinant Virus Expressing Green Fluorescent Protein , 2002, Journal of Virology.
[49] E. ten Dam,et al. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. , 2001, The Journal of general virology.
[50] David E. Swayne,et al. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] Amer A. Beg,et al. Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.
[52] S. Goodbourn,et al. The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation , 1999, Journal of Virology.
[53] Walter Fiers,et al. A universal influenza A vaccine based on the extracellular domain of the M2 protein , 1999, Nature Medicine.
[54] G. Kaplan,et al. The distinctive features of influenza virus infection of dendritic cells. , 1998, Immunobiology.
[55] G T Montelione,et al. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. , 1995, RNA.
[56] R. Webster,et al. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. , 1994, Virology.
[57] A. García-Sastre,et al. Expression of a foreign protein by influenza A virus , 1994, Journal of virology.
[58] M. Ryan,et al. Foot‐and‐mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. , 1994, The EMBO journal.
[59] M. Ryan,et al. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. , 1991, The Journal of general virology.
[60] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[61] L. J. Reed. A simple method of estimating fifty per cent end-points. , 1938 .